Rasagiline (Azilate) usage and dosage and individualized adjustment recommendations for different patients

Rasagiline (Rasagiline) is a selective monoamine oxidaseB (MAO-B) inhibitor. It is mainly used for the monotherapy of Parkinson's disease or as an adjuvant drug for combination therapy with levodopa. Its mechanism of action is to inhibit the decomposition of dopamine by MAO-B, thereby increasing the level of dopamine in the brain and improving motor symptoms. Rasagiline is usually used in the form of oral tablets. The standard recommended dose is 1 mg once daily. It can be taken with or without food. Maintaining it for a fixed time will help stabilize the blood concentration and exert its therapeutic effect.

For patients with early-stage Parkinson's disease, especially when treated with a single drug, doctors generally recommend a fixed dose of 1mg per day. This dose has shown good efficacy and tolerability in clinical studies and can effectively delay the progression of symptoms. Patients should take the medicine regularly according to the doctor's instructions and do not increase or decrease the dose at will to avoid fluctuations in drug concentration that may lead to unstable efficacy or adverse reactions, such as dizziness, insomnia or nausea.

Individualized adjustment is particularly important for patients with moderate to advanced Parkinson's disease treated with levodopa. Doctors will make a comprehensive assessment based on the patient's severity of motor symptoms, levodopa dosage and tolerance. The dosage is usually maintained at 1 mg per day. However, in some patients with drug interactions or abnormal liver function, it may be necessary to extend the medication interval or adjust the dosage of the combined medication to ensure safety and efficacy. For elderly patients or those with mild to moderate impairment of liver function, adverse reactions should be closely monitored and dose optimization should be performed if necessary.

In addition, patients should pay attention to drug interactions with diet and other drugs when using rasagiline. Avoid ingesting large amounts of foods containing high tyrosine or high tyramine at the same time, and use drugs that may affect the activity of MAO-B with caution. Through individualized dose adjustment, regular medication and regular follow-up, the efficacy of rasagiline can be maximized while reducing the risk of side effects, helping patients to stably control the motor symptoms of Parkinson's disease in the long term and improve their quality of life.

Reference link:https://www.drugs.com